LOR-253: Phase Ib start

In mid-September, Lorus will begin an open-label, U.S. Phase Ib trial

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE